- Feb 5, 2002
- 166,683
- 56,293
- Country
- United States
- Faith
- Catholic
- Marital Status
- Married
- Politics
- US-Others
Citing serious health risks and a lack of supporting evidence, Sweden, France and England have all adopted a more critical stance toward ‘gender affirming care’ for youth — a stark difference to the approach taken in many US states and cultural institutions.
At both the federal and the state level, and in the American culture more broadly, there is a concerted effort to remove obstacles to minors’ access to controversial “gender affirming care.”
California, Minnesota and New York have passed legislation establishing their state as a “trans youth refuge,” while the federal government is challenging the legality of state-level restrictions placed on practices like hormone therapy and “sex-reassignment surgery.” Even an academic journal was pressured into retracting a study on “rapid onset gender dysphoria” after pushback from activists.
In Europe, however, a trend in the opposite direction is unfolding. Judging that the scientific evidence is lacking, that long-term effects remain unknown and that the benefits are outweighed by the risks, governments and health authorities in at least five countries — several of which pioneered in “gender-affirming” hormonal and surgical treatments for minors — seem to be re-examining their decisions.
What’s more, in a letter published in The Wall Street Journal on July 13, clinicians and researchers from nine countries, mainly European, stepped forward to criticize the recently made statement by the president of the American-based Endocrine Society, according to whom “gender-affirming care improves the well-being of transgender and gender-diverse people.”
Continued below.
www.ncregister.com
At both the federal and the state level, and in the American culture more broadly, there is a concerted effort to remove obstacles to minors’ access to controversial “gender affirming care.”
California, Minnesota and New York have passed legislation establishing their state as a “trans youth refuge,” while the federal government is challenging the legality of state-level restrictions placed on practices like hormone therapy and “sex-reassignment surgery.” Even an academic journal was pressured into retracting a study on “rapid onset gender dysphoria” after pushback from activists.
In Europe, however, a trend in the opposite direction is unfolding. Judging that the scientific evidence is lacking, that long-term effects remain unknown and that the benefits are outweighed by the risks, governments and health authorities in at least five countries — several of which pioneered in “gender-affirming” hormonal and surgical treatments for minors — seem to be re-examining their decisions.
What’s more, in a letter published in The Wall Street Journal on July 13, clinicians and researchers from nine countries, mainly European, stepped forward to criticize the recently made statement by the president of the American-based Endocrine Society, according to whom “gender-affirming care improves the well-being of transgender and gender-diverse people.”
‘The Risks Outweigh the Benefits’
Continued below.
European Countries’ Restrictions on Gender Treatment for Minors Contrasts Sharply With US Push
Citing serious health risks and a lack of supporting evidence, Sweden, France and England have all adopted a more critical stance toward ‘gender affirming care’ for youth — a stark difference to the approach taken in many US states and cultural institutions.
